GGrantIndex
← Leaderboards

Tianxi Cai

Harvard School Of Public Health

$4,726,752
Attributed
$8,074,261
Total exposure
6
Grants
3
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $2.1M · FY200725
$2.5M$1.9M$1.3M$625K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$5,916,388 · 5
FDA$2,157,873 · 1

By mechanism

R01$5,102,110 · 3
U01$2,157,873 · 1
R21$814,278 · 2

Top collaborators

Most similar at Harvard School Of Public Health

Same institution · by research overlap

Others in their field

Top investigators on “Clinical Trials

Research focus

Clinical TrialsClinical DataData SetBaseMeasurementSupervised LearningElectronic Health RecordProceduresTreatment ResponseBiologicalAlgorithmsRegistriesResearch DesignComplexMethodologyInflammatoryComputer SoftwareDisorder RiskPatient PopulationTnf GeneRheumatoid ArthritisSourceCostSubgroup

Grant awards (21)

Bridging clinical trial and real-world data via machine learning to advance rheumatoid arthritis treatment strategies$611,626
R01 · FY2025 · AR
Generating Reproducible Real-World Evidence with Multi-Source Data to Capture Unstructured Clinical Endpoints for Chronic Diseases$1,103,420
U01 · FY2024 · FD
Bridging clinical trial and real-world data via machine learning to advance rheumatoid arthritis treatment strategies$663,519
R01 · FY2024 · AR
Semi-supervised Approaches to Denoising Electronic Health Records Data for Risk Prediction$334,713
R01 · FY2024 · LM · contact PI
Generating Reproducible Real-World Evidence with Multi-Source Data to Capture Unstructured Clinical Endpoints for Chronic Diseases$1,054,453
U01 · FY2023 · FD
Bridging clinical trial and real-world data via machine learning to advance rheumatoid arthritis treatment strategies$695,228
R01 · FY2023 · AR
Semi-supervised Approaches to Denoising Electronic Health Records Data for Risk Prediction$334,713
R01 · FY2023 · LM · contact PI
Bridging clinical trial and real-world data via machine learning to advance rheumatoid arthritis treatment strategies$748,363
R01 · FY2022 · AR
Semi-supervised Approaches to Denoising Electronic Health Records Data for Risk Prediction$337,425
R01 · FY2022 · LM · contact PI
Studying exceptional treatment non-responders and genetics to predict treatment response in rheumatoid arthritis$192,876
R21 · FY2022 · AR
Semi-supervised Approaches to Denoising Electronic Health Records Data for Risk Prediction$367,175
R01 · FY2021 · LM · contact PI
Studying exceptional treatment non-responders and genetics to predict treatment response in rheumatoid arthritis$251,507
R21 · FY2021 · AR
Semi-supervised Algorithms for Risk Assessment with Noisy EHR Data$177,510
R21 · FY2020 · CA · contact PI
Semi-supervised Algorithms for Risk Assessment with Noisy EHR Data$192,385
R21 · FY2019 · CA · contact PI
Robust Approaches to the Development and Evaluation of Prognostic Classifiers$161,500
R01 · FY2014 · GM · contact PI
Robust Approaches to the Development and Evaluation of Prognostic Classifiers$155,848
R01 · FY2013 · GM · contact PI
Robust Approaches to the Development and Evaluation of Prognostic Classifiers$161,500
R01 · FY2012 · GM · contact PI
Robust Approaches to the Development and Evaluation of Prognostic Classifiers$161,500
R01 · FY2011 · GM · contact PI
Robust Approaches to the Development and Evaluation of Prognostic Classifiers$123,000
R01 · FY2009 · GM · contact PI
Robust Approaches to the Development and Evaluation of Prognostic Classifiers$123,000
R01 · FY2008 · GM · contact PI
Robust Approaches to the Development and Evaluation of Prognostic Classifiers$123,000
R01 · FY2007 · GM · contact PI